Lymphoma, T-Cell, Peripheral
"Lymphoma, T-Cell, Peripheral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment.
| Descriptor ID |
D016411
|
| MeSH Number(s) |
C04.557.386.480.750.825 C15.604.515.569.480.750.825 C20.683.515.761.480.750.825
|
| Concept/Terms |
Lymphoma, T-Cell, Peripheral- Lymphoma, T-Cell, Peripheral
- T-Cell Lymphoma, Peripheral
- T Cell Lymphoma, Peripheral
- Lymphoma, T Cell, Peripheral
- Peripheral T-Cell Lymphoma
- Lymphoma, Peripheral T-Cell
- Lymphomas, Peripheral T-Cell
- Peripheral T Cell Lymphoma
- Peripheral T-Cell Lymphomas
- T-Cell Lymphomas, Peripheral
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell, Peripheral".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Peripheral [C04.557.386.480.750.825]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Peripheral [C15.604.515.569.480.750.825]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Peripheral [C20.683.515.761.480.750.825]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell, Peripheral".
This graph shows the total number of publications written about "Lymphoma, T-Cell, Peripheral" by people in this website by year, and whether "Lymphoma, T-Cell, Peripheral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, T-Cell, Peripheral" by people in Profiles.
-
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach. Mod Pathol. 2025 Feb; 38(2):100646.
-
Peripheral T-cell lymphoma with TFH phenotype and associated indolent T-lymphoblastic proliferation. Blood. 2023 08 03; 142(5):493.
-
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 05 04; 141(18):2194-2205.
-
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas. Hum Pathol. 2022 07; 125:48-58.
-
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma. Blood Adv. 2020 10 13; 4(19):4640-4647.
-
A peripheral cause of asthma: Peripheral T-cell lymphoma. Ann Allergy Asthma Immunol. 2019 04; 122(4):420-422.
-
Peripheral T-cell lymphoma - are we making progress? Best Pract Res Clin Haematol. 2018 09; 31(3):306-314.
-
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. Lancet Haematol. 2018 May; 5(5):e190-e200.
-
Composite lymphoma of follicular B-cell and peripheral T-cell types with distinct zone distribution in a 75-year-old male patient: a case study. Hum Pathol. 2018 06; 76:110-116.
-
Cyclin D1 expression in peripheral T-cell lymphomas. Mod Pathol. 2016 11; 29(11):1306-1312.